Rat haptoglobin is a plasma glycoprotein primarily responsible for binding free hemoglobin released during red blood cell breakdown, thereby preventing hemoglobin-induced oxidative tissue damage and facilitating its clearance via the reticuloendothelial system2. Structurally, rat haptoglobin is a heterotetramer composed of two alpha and two glycosylated beta subunits linked by disulfide bonds, and it exhibits significant polymorphism, resulting in multiple phenotypes with varying molecular weights and polymeric structures. These structural variants influence the protein’s antioxidant capacity and are linked to different susceptibilities to disease.

Altered haptoglobin levels or function in rats are associated with hemolytic anemia, kidney injury due to hemoglobin accumulation, and increased risk of oxidative stress-related diseases. In biomedical research, rat haptoglobin serves as a biomarker for hemolytic conditions and inflammation, and is used in studies of oxidative stress, immune response, and as a model for understanding haptoglobin's role in human health and disease.